Health Condition 1: C51-C58- Malignant neoplasms of female genital organs
Conditions
Interventions
None listed
Sponsors
Kasturba Medical College and Kasturba Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Women with biopsy proven cervical, Endometrial, and Ovarian Cancers Woman with Cervical pre-cancers and borderline ovarian tumours Woman with uterine sarcomas
Exclusion criteria
Exclusion criteria: Women who have already started treatment Women referred with biopsy report and no further IHC evaluation suggested
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Outcome of the study is to find the indications to do IHC Markers in the biopsy specimens (Tests will be done at the discretion of the treating clinician and pathologist)Timepoint: Hence IHC is only done at one time point when the pathologist or clinician decides during the evaluation of the biopsy specimen | — |
Secondary
| Measure | Time frame |
|---|---|
| Use the relevant markers as a guide to dictate diagnosis, treatment protocol & Prognosis.Timepoint: Hence IHC is only done at one time point when the pathologist or clinician decides during the evaluation of the biopsy specimen | — |
Countries
India
Contacts
Public ContactDr Sonika Gupta
Kasturba Medical College, Manipal
Outcome results
None listed